Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

BACKGROUND: Treatment of pulmonary sarcoidosis is recommended in case of significant symptoms, impaired or deteriorating lung function. Evidence-based treatment recommendations are limited and largely based on expert opinion. Prednisone is currently the first-choice therapy and leads to short-term i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahlmann, Vivienne, Janssen Bonás, Montse, Moor, Catharina C., van Moorsel, Coline H. M., Kool, Mirjam, Kraaijvanger, Raisa, Grutters, Jan C., Overgaauw, Mayka, Veltkamp, Marcel, Wijsenbeek, Marlies S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574228/
https://www.ncbi.nlm.nih.gov/pubmed/33076885
http://dx.doi.org/10.1186/s12890-020-01290-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574228/
https://www.ncbi.nlm.nih.gov/pubmed/33076885
http://dx.doi.org/10.1186/s12890-020-01290-9

Ejemplares similares